Migraine as Inspiration in Painting
September 16th 2009Did Pablo Picasso suffer from migraine? And did these episodes influence his artwork? Not likely, said Joost Haan, MD, PhD, a member of the department of neurology at Leiden University Medical Centre, Leiden, the Netherlands. He discussed migraine and the works of master painters at the 14th annual International Headache Congress in Philadelphia.
Large Study Shows onabotulinumtoxinA to Be Effective for Chronic Migraine Treatment and Prophylaxis
September 15th 2009Results of a landmark study showed that onabotulinumtoxinA effectively reduced headache symptoms, episodes, disability, and health-related quality of life in patients with chronic migraine.
Study Shows Migraineurs With Comorbid Mood Disorders Responded Well to Treatment
September 15th 2009Patients with migraine accompanied by depression or anxiety disorders had greater improvements in headache-related disability than those without a psychiatric disorder, according to results of the Treatment of Severe Migraine trial.
Chronic Daily Headache Is Prevalent Among Soldiers With Mild Head Trauma
September 15th 2009About 20% of soldiers returning from Iraq and Afghanistan who have a history of concussion or blast exposure experience chronic daily headache, according to a results of study presented at the 14th annual International Headache Congress in Philadelphia.
Tonabersat May Be Helpful for the Prevention of Aura Associated With Migraine
September 11th 2009Tonabersat is effective in the prophylaxis of aura in patients with migraine, according to a recent study led by Jes Olesen, MD, a professor of neurology at the Danish Headache Center at Glostrup Hospital, University of Copenhagen, Glostrup, Denmark.
TMD Associated With Frequency of Migraine and Chronic Daily Headache
September 11th 2009Patients with migraine are more likely than nonmigraineurs to have temporomandibular disorder (TMD). According to the results of a new study presented at the 14th annual International Headache Conference in Philadelphia, TMD may also be associated with increased headache frequency.
Improved Acute Ischemic Stroke Outcomes With tPA
May 2nd 2009An analysis of 1274 patients with acute ischemic stroke (AIS) admitted to a single Colorado medical center over a 2-year period found that application of any acute stroke treatment strategy improved the patients’ NIH Stroke Scale (NIHSS) score.
Orthostatic Hypotension Increases the Risk of Alzheimer Disease
May 2nd 2009Alzheimer disease (AD) is more than twice as likely to develop in elderly persons with orthostatic hypotension (OH) as in those without OH, according to a new study presented at the Annual Meeting of the American Academy of Neurology.
Chronic Migraine Patients Also Burdened With Higher Medical Costs
May 1st 2009The total direct and indirect costs for treating patients with chronic migraines (CM) are 2.6 times higher than costs associated with episodic migraine (EM). Containing those costs through better management of the illness should be a priority, according to migraine researchers who led a nationwide study comparing the costs of CM and EM as part of the American Migraine Prevalence and Prevention (AMPP) Study.
Adding Corticosteroid to MS Regimen May Reduce Disease Activity
April 30th 2009The addition of methylprednisolone to interferon ß (IFN-ß) therapy may reduce disease activity in patients with multiple sclerosis (MS) to a greater degree than treatment with IFN-ß alone. “These results indicate that these 2 drugs may have a synergy when taken together and provide a more beneficial effect on the disease activity,” said study author Mads Ravnborg, MD, of the Danish Multiple Sclerosis Research Center at Copenhagen University Hospital in Denmark.
Painful Diabetic Peripheral Neuropathy: Options for Treatment
April 30th 2009New treatment options for pain caused by diabetic peripheral neuropathy were presented at the annual meeting of the American Academy of Neurology. While oral medications from 2 different drug classes appear effective, injection of botulinum toxin does not.
Are Primary Stroke Centers Living Up to Potential?
April 30th 2009Thirteen years have passed since intravenous tissue plasminogen activator was approved for treating patients with acute ischemic stroke, but some experts think hospitals-even those designated as primary stroke centers-have been slow to implement the strategy.